drugset / Trial / NCT02334046

Remifentanil for Smooth Emergence in Elderly Patients

NCT02334046

Phase 4 Completed 47 enrolled Ajou University School of Medicine
Non-randomizedParallel-groupSingle-blindPrevention

Summary

Elderly patients show different pharmacokinetic and pharmacodynamic variables and usually need smaller doses of anaesthetic drugs than younger patients. The purpose of this study was to investigate the optimal effect-site concentration of remifentanil for preventing cough during emergence in elderly patients under sevoflurane and remifentanil anesthesia.

Timeline

Start
2015-02
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 1.8 ng/ml
Background Sevoflurane Other / unclassified 1.5 %
Background Sevoflurane Other / unclassified 2 %

Indications